PQNT - ETF AI Analysis
Top Page
Pictet AI Enhanced International Equity ETF (PQNT)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Leading Holding
The largest position, ASML Holding, has shown strong performance, which can help support the ETF’s overall returns.
Broad International Diversification
The fund spreads its investments across many countries such as Japan, the UK, France, Germany, and others, reducing reliance on any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, health care, technology, and several other sectors, which can help smooth out sector-specific ups and downs.
Negative Factors
Recent Short-Term Weakness
The ETF has had a weak recent one-month performance, which may signal short-term volatility or pressure on its holdings.
Several Top Holdings Are Lagging
Some key positions like Sony, SAP, EssilorLuxottica, and ING have been weak this year, which can drag on the fund’s results.
Small Asset Base
The fund manages a relatively small amount of assets, which can sometimes mean lower trading volume and wider bid-ask spreads for investors.
PQNT vs. SPDR S&P 500 ETF (SPY)
AUM10.97M
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.85
IssuerPictet
Inception DateOct 15, 2025
Dividend Yield0.38%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,453
30 Day Avg. Volume5,974
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
25.46Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering293
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PQNT Summary
Pictet AI Enhanced International Equity ETF (PQNT) is an actively managed fund that uses artificial intelligence to pick stocks from developed markets outside North America, such as Japan, the UK, and Europe. It invests across many sectors, including financials, industrials, health care, and technology. Well-known holdings include ASML, Sony, AstraZeneca, and BP. Someone might invest in PQNT to get broad international diversification and the potential for growth from AI-driven stock selection. A key risk is that international stock prices can go up and down significantly, and the AI strategy does not guarantee better results.
How much will it cost me?The Pictet AI Enhanced International Equity ETF (PQNT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, using advanced AI technology to select investments rather than following a passive index. Active management typically involves more research and strategy, which increases costs.
What would affect this ETF?The Pictet AI Enhanced International Equity ETF (PQNT) could benefit from advancements in artificial intelligence and strong performance in developed markets outside North America, particularly in sectors like Financials, Industrials, and Technology, which make up a significant portion of its holdings. However, it may face challenges from global economic slowdowns, regulatory changes in international markets, or sector-specific risks, such as volatility in the Financial sector or slower growth in Technology. Additionally, currency fluctuations and geopolitical tensions in developed markets could negatively impact returns.
PQNT Top 10 Holdings
PQNT leans into a mix of European and Asian heavyweights, with chip-gear giant ASML doing much of the heavy lifting as its share price keeps climbing. Health care names like AstraZeneca and Roche are also quietly pulling their weight, giving the fund a defensive backbone. On the other side, software leader SAP and consumer staple Unilever have been losing steam, acting as mild brakes on performance, while Sony and EssilorLuxottica are stuck in a more mixed gear. Overall, it’s a diversified developed-markets ex-U.S. play, not a one-sector bet.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.29% | $364.03K | €477.33B | 106.32% | 76 Outperform | |
| AstraZeneca | 2.08% | $229.86K | $292.69B | 32.74% | 80 Outperform | |
| SAP SE | 1.76% | $194.60K | €171.96B | -40.47% | 66 Neutral | |
| Sony | 1.49% | $164.63K | ¥19.60T | -17.91% | 73 Outperform | |
| Roche Holding AG | 1.33% | $147.60K | $327.04B | 22.13% | ― | |
| EssilorLuxottica SA | 1.27% | $140.61K | €85.81B | -25.83% | 68 Neutral | |
| Deutsche Bank AG | 1.24% | $137.19K | $59.37B | 24.01% | 69 Neutral | |
| Hitachi,Ltd. | 1.24% | $136.84K | ¥23.65T | 25.90% | 77 Outperform | |
| ING GROEP | 1.23% | $135.81K | €67.59B | 40.19% | 61 Neutral | |
| Unilever | 1.22% | $134.88K | £93.54B | ― | 72 Outperform |
PQNT Technical Analysis
Negative
―
Price Trends
21.73
Negative
21.60
Positive
Market Momentum
0.13
Positive
46.01
Neutral
0.29
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PQNT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 22.03, equal to the 50-day MA of 21.73, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.13 indicates Positive momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 0.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PQNT.
PQNT Peer Comparison
Comparison Results
Performance Comparison
PQNT
Pictet AI Enhanced International Equity ETF
21.65
1.52
7.55%
QUIZ
Zacks Quality International ETF
―
―
―
AIVI
WisdomTree International AI Enhanced Value Fund
―
―
―
TACN
T. Rowe Price Active Core International Equity ETF
―
―
―
JIDE
JPMorgan International Dynamic ETF
―
―
―
IVSI
Applied Finance IVS International Large ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents